| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
37,043 |
29,332 |
$9.70M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
27,072 |
23,003 |
$3.76M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,828 |
4,142 |
$2.64M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,074 |
2,420 |
$1.31M |
| C1776 |
Joint device (implantable) |
361 |
254 |
$1.10M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
17,055 |
13,586 |
$1.06M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,612 |
4,009 |
$993K |
| G0378 |
Hospital observation service, per hour |
2,007 |
1,507 |
$808K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
14,698 |
11,523 |
$674K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,351 |
1,155 |
$623K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
10,021 |
8,850 |
$595K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,256 |
16,030 |
$588K |
| 71045 |
Radiologic examination, chest; single view |
11,366 |
9,638 |
$560K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,084 |
6,140 |
$489K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,556 |
8,149 |
$476K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,578 |
9,080 |
$404K |
| 71046 |
Radiologic examination, chest; 2 views |
5,270 |
4,722 |
$300K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,601 |
3,072 |
$248K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,074 |
940 |
$226K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,760 |
2,064 |
$223K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,101 |
3,435 |
$214K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,284 |
1,100 |
$197K |
| 80053 |
Comprehensive metabolic panel |
34,268 |
26,004 |
$189K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
150 |
110 |
$180K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,130 |
4,115 |
$172K |
| 85027 |
|
39,130 |
29,180 |
$128K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,061 |
1,046 |
$127K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,243 |
954 |
$122K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,422 |
2,926 |
$121K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,644 |
5,344 |
$114K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,578 |
8,370 |
$110K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
711 |
615 |
$101K |
| 70486 |
|
330 |
289 |
$101K |
| 96376 |
|
3,358 |
2,200 |
$100K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,591 |
2,335 |
$97K |
| 84484 |
|
14,623 |
7,742 |
$84K |
| 73564 |
|
727 |
614 |
$83K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,236 |
1,716 |
$79K |
| 83880 |
|
4,649 |
3,974 |
$79K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
784 |
681 |
$78K |
| 93971 |
|
811 |
674 |
$77K |
| C1769 |
Guide wire |
491 |
378 |
$75K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,807 |
1,707 |
$73K |
| 73030 |
|
1,239 |
1,074 |
$72K |
| 73610 |
|
1,159 |
1,006 |
$70K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
380 |
292 |
$67K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,763 |
3,796 |
$65K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
17,515 |
13,568 |
$65K |
| J2060 |
Injection, lorazepam, 2 mg |
2,410 |
1,739 |
$56K |
| 73630 |
|
948 |
811 |
$55K |
| 84703 |
|
9,874 |
8,026 |
$52K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,901 |
1,715 |
$52K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,955 |
1,671 |
$49K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,959 |
1,673 |
$49K |
| 83690 |
|
13,251 |
10,624 |
$48K |
| J2704 |
Injection, propofol, 10 mg |
4,387 |
3,623 |
$45K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
414 |
355 |
$45K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
162 |
122 |
$44K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,610 |
3,522 |
$44K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,068 |
771 |
$43K |
| J3535 |
Drug administered through a metered dose inhaler |
1,095 |
969 |
$41K |
| 72100 |
|
760 |
660 |
$40K |
| 10060 |
|
344 |
302 |
$39K |
| 93975 |
|
194 |
166 |
$36K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
2,166 |
1,899 |
$36K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,923 |
3,358 |
$34K |
| 70498 |
|
149 |
128 |
$34K |
| 87040 |
|
5,368 |
2,390 |
$32K |
| J3490 |
Unclassified drugs |
3,699 |
2,782 |
$31K |
| 73130 |
|
492 |
421 |
$31K |
| 73110 |
|
539 |
449 |
$30K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
106 |
96 |
$29K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,036 |
3,041 |
$29K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,874 |
2,184 |
$28K |
| 12001 |
|
250 |
227 |
$27K |
| 73502 |
|
527 |
447 |
$27K |
| 74018 |
|
380 |
327 |
$27K |
| 82077 |
|
2,924 |
2,032 |
$26K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,725 |
6,466 |
$26K |
| 83605 |
|
4,143 |
2,983 |
$25K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,119 |
6,216 |
$24K |
| 83735 |
|
6,829 |
5,271 |
$22K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,454 |
1,234 |
$22K |
| 86141 |
|
2,719 |
2,127 |
$21K |
| 80143 |
|
1,715 |
1,350 |
$19K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,796 |
3,062 |
$19K |
| 81001 |
|
10,475 |
8,816 |
$19K |
| 80179 |
|
1,604 |
1,276 |
$18K |
| 90715 |
|
1,359 |
1,248 |
$18K |
| 73080 |
|
228 |
191 |
$17K |
| 70496 |
|
80 |
67 |
$16K |
| J1790 |
Injection, droperidol, up to 5 mg |
1,032 |
825 |
$16K |
| 85379 |
|
2,749 |
2,396 |
$16K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
747 |
648 |
$16K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,468 |
3,593 |
$16K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,278 |
2,839 |
$15K |
| 73560 |
|
329 |
241 |
$15K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,164 |
1,791 |
$14K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
494 |
226 |
$14K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
782 |
683 |
$14K |
| 76801 |
|
261 |
228 |
$13K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
161 |
121 |
$13K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,009 |
702 |
$12K |
| 84702 |
|
1,011 |
834 |
$12K |
| 76830 |
Ultrasound, transvaginal |
172 |
143 |
$11K |
| 97116 |
|
548 |
302 |
$11K |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
906 |
781 |
$11K |
| 85610 |
|
4,820 |
3,719 |
$9K |
| 82550 |
|
2,548 |
2,047 |
$8K |
| 73590 |
|
162 |
138 |
$8K |
| 72131 |
|
26 |
26 |
$8K |
| 86850 |
|
1,707 |
1,228 |
$8K |
| 87077 |
|
1,351 |
1,141 |
$8K |
| C9113 |
Injection, pantoprazole sodium, per vial |
861 |
655 |
$8K |
| 80074 |
|
229 |
198 |
$8K |
| 73562 |
|
90 |
82 |
$8K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
19 |
16 |
$7K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
30 |
27 |
$7K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
536 |
462 |
$7K |
| 72040 |
|
91 |
79 |
$7K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
133 |
124 |
$7K |
| 81003 |
|
5,038 |
4,277 |
$7K |
| 97535 |
Self-care/home management training, each 15 minutes |
348 |
205 |
$7K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
422 |
209 |
$7K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
32 |
27 |
$7K |
| 85730 |
|
2,458 |
1,840 |
$7K |
| 87186 |
|
1,088 |
938 |
$6K |
| 70491 |
|
15 |
12 |
$6K |
| 76000 |
|
56 |
41 |
$6K |
| 88307 |
|
21 |
15 |
$6K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,151 |
983 |
$6K |
| 12002 |
|
42 |
41 |
$5K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
751 |
579 |
$5K |
| 88342 |
|
126 |
83 |
$5K |
| 85651 |
|
2,024 |
1,641 |
$5K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
17 |
12 |
$5K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,579 |
1,732 |
$5K |
| J1630 |
Injection, haloperidol, up to 5 mg |
637 |
477 |
$5K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
2,333 |
2,084 |
$5K |
| 73120 |
|
77 |
63 |
$4K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
29 |
24 |
$4K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
31 |
26 |
$4K |
| 87070 |
|
682 |
528 |
$4K |
| 84439 |
|
711 |
594 |
$4K |
| 86900 |
|
2,132 |
1,602 |
$3K |
| 86901 |
|
2,132 |
1,602 |
$3K |
| 12011 |
|
27 |
27 |
$3K |
| 87205 |
|
1,145 |
857 |
$3K |
| 97162 |
|
109 |
82 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
499 |
439 |
$3K |
| 97163 |
|
80 |
54 |
$2K |
| 71250 |
|
14 |
12 |
$2K |
| 73140 |
|
42 |
36 |
$2K |
| 86780 |
|
221 |
176 |
$2K |
| 86592 |
|
506 |
435 |
$2K |
| 71101 |
|
15 |
13 |
$1K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
32 |
25 |
$1K |
| 73090 |
|
28 |
27 |
$1K |
| J1953 |
Injection, levetiracetam, 10 mg |
71 |
37 |
$1K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
14 |
13 |
$1K |
| 99152 |
|
104 |
75 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$982.47 |
| 81025 |
|
152 |
139 |
$971.65 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
63 |
60 |
$964.96 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
122 |
79 |
$909.92 |
| 80061 |
Lipid panel |
138 |
112 |
$852.92 |
| 87631 |
|
145 |
142 |
$728.17 |
| J1940 |
Injection, furosemide, up to 20 mg |
118 |
92 |
$724.86 |
| 82728 |
|
97 |
72 |
$629.05 |
| 72170 |
|
22 |
14 |
$569.29 |
| S0028 |
Injection, famotidine, 20 mg |
308 |
250 |
$561.63 |
| 97166 |
|
14 |
12 |
$473.87 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
564 |
452 |
$443.06 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
276 |
208 |
$433.67 |
| J1644 |
Injection, heparin sodium, per 1000 units |
209 |
114 |
$411.64 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
17 |
13 |
$368.14 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
142 |
115 |
$350.96 |
| 84100 |
|
111 |
78 |
$301.62 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
151 |
131 |
$288.79 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
191 |
143 |
$246.69 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
111 |
96 |
$218.36 |
| 82248 |
|
72 |
53 |
$215.86 |
| J7999 |
Compounded drug, not otherwise classified |
80 |
60 |
$155.24 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
215 |
185 |
$142.17 |
| 87075 |
|
24 |
16 |
$129.29 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
376 |
291 |
$109.05 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
12 |
12 |
$101.53 |
| 83615 |
|
31 |
27 |
$96.64 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
153 |
141 |
$78.69 |
| G0435 |
Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening |
631 |
535 |
$72.83 |
| 83540 |
|
14 |
12 |
$56.95 |
| 83930 |
|
16 |
13 |
$46.27 |
| J3360 |
Injection, diazepam, up to 5 mg |
28 |
25 |
$29.12 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
86 |
67 |
$24.67 |
| 36415 |
Collection of venous blood by venipuncture |
6,927 |
5,747 |
$22.55 |
| 80076 |
|
17 |
17 |
$10.09 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,406 |
1,253 |
$8.92 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
1,337 |
1,053 |
$0.01 |
| A9270 |
Non-covered item or service |
23,251 |
7,588 |
$0.00 |
| 80320 |
|
3,874 |
2,962 |
$0.00 |
| 82553 |
|
27 |
26 |
$0.00 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
54 |
48 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
174 |
146 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
29 |
15 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
344 |
291 |
$0.00 |